| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/12/2003 | CA2468701A1 T-bet compositions and methods of use thereof |
| 06/12/2003 | CA2468565A1 Transgenic animals bearing human iglambda light chain genes |
| 06/12/2003 | CA2468432A1 Nucleotide analogues and their use for nucleic acid sequencing |
| 06/12/2003 | CA2468407A1 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 06/12/2003 | CA2468259A1 Antibody to latent membrane proteins and uses thereof |
| 06/12/2003 | CA2467738A1 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen |
| 06/12/2003 | CA2467597A1 Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection |
| 06/12/2003 | CA2467486A1 Vaccine |
| 06/12/2003 | CA2467363A1 Polycistronic expression of antibodies |
| 06/12/2003 | CA2467073A1 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases |
| 06/12/2003 | CA2466413A1 Flavivirus ns1 subunit vaccine |
| 06/12/2003 | CA2464897A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 06/12/2003 | CA2462966A1 Factor viii c2 domain variants |
| 06/12/2003 | CA2438297A1 Gene targeting methods and vectors |
| 06/11/2003 | EP1318407A1 Use of aldose-1-epimerase (mutarotase) for the diagnosis and therapy of infections and sepsis |
| 06/11/2003 | EP1318401A2 Method for the early detection of the seroconversion of an anti hepatitis C virus antibody |
| 06/11/2003 | EP1318203A2 Method for the amplification of nucleic acids based on elongation and displacement |
| 06/11/2003 | EP1318200A2 Methods for producing optically active alcohols |
| 06/11/2003 | EP1318198A1 Process for producing a recombinant polypeptide involving the addition of an inhibitor of chymotrypsins to the cell culture medium |
| 06/11/2003 | EP1318197A1 Thermotolerant ribonuclease h |
| 06/11/2003 | EP1318196A1 Amino acid producing strains belonging to the genus Escherichia and method for producing amino acid |
| 06/11/2003 | EP1318195A1 A structure for presenting desired peptide sequences |
| 06/11/2003 | EP1318193A2 D-amidase from Variovorax |
| 06/11/2003 | EP1318192A2 Prenyltransferase from Arabidopsis |
| 06/11/2003 | EP1317669A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 06/11/2003 | EP1317569A1 Microfluidic devices and methods for performing temperature mediated reactions |
| 06/11/2003 | EP1317568A2 Method of sequencing dna |
| 06/11/2003 | EP1317566A2 Single primer pcr amplification of rna |
| 06/11/2003 | EP1317565A2 Method for controlling the microbiological quality of an aqueous medium and kit therefor |
| 06/11/2003 | EP1317562A2 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds |
| 06/11/2003 | EP1317561A2 Modulation of homologous recombination with single stranded dna binding proteins |
| 06/11/2003 | EP1317560A1 Self-rearranging dna vectors |
| 06/11/2003 | EP1317559A2 Dna transfection system for the generation of infectious influenza virus |
| 06/11/2003 | EP1317558A2 A method for producing plants which are resistant to closteroviruses |
| 06/11/2003 | EP1317557A2 Compositions and methods for stable transformation using mu bacteriophage cleaved donor complex |
| 06/11/2003 | EP1317556A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug |
| 06/11/2003 | EP1317555A1 Rat cathepsin, dipeptidyl peptidase i (dppi): crystal structure, inhibitors and its uses |
| 06/11/2003 | EP1317554A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 06/11/2003 | EP1317553A2 Pdes and uses thereof |
| 06/11/2003 | EP1317552A2 23430, a novel human ubiquitin hydrolase family member and uses therefor |
| 06/11/2003 | EP1317551A2 Human phospholipases and polynucleotides encoding the same |
| 06/11/2003 | EP1317550A2 Nucleotide sequences which code for the ppsa gene |
| 06/11/2003 | EP1317549A1 Isolation and sequencing of the ptsi gene of c. glutamicum |
| 06/11/2003 | EP1317548A2 Transglutaminase gene products |
| 06/11/2003 | EP1317547A1 Isolation and sequencing of the pknb gene of c. glutamicum |
| 06/11/2003 | EP1317545A2 Nucleotide sequences coding for the pknd gene |
| 06/11/2003 | EP1317544A1 Novel diagnostic agents of chronic or persistent chlamydial diseases and uses thereof |
| 06/11/2003 | EP1317543A1 Parietaria judaica ns-ltp antigen variants, uses thereof and compositions comprising them |
| 06/11/2003 | EP1317541A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/11/2003 | EP1317540A2 Imidazoline receptor homologs |
| 06/11/2003 | EP1317539A2 Directed evolution method |
| 06/11/2003 | EP1317538A1 Novel compounds |
| 06/11/2003 | EP1317537A2 G-csf analog compositions and methods |
| 06/11/2003 | EP1317536A2 Tnf receptor-like molecules and uses thereof |
| 06/11/2003 | EP1317535A2 Constructs and their use in metabolic pathway engineering |
| 06/11/2003 | EP1317532A2 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease |
| 06/11/2003 | EP1317531A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 06/11/2003 | EP1317530A2 27877, a phospholipase and uses therefor |
| 06/11/2003 | EP1317527A2 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses |
| 06/11/2003 | EP1317488A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 06/11/2003 | EP1317486A1 Interferon-alpha induced gene |
| 06/11/2003 | EP1317485A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 06/11/2003 | EP1317484A2 VARIANTS OF i PHLEUM PRATENSE /i ALLERGENIC PROTEINS |
| 06/11/2003 | EP1317483A2 Variants of allergenic proteins of the group 2 of dermatophagoides |
| 06/11/2003 | EP1317481A2 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene |
| 06/11/2003 | EP1317480A2 Rabbit hemorrhagic disease vaccine and antigens |
| 06/11/2003 | EP1317479A2 Methods and compositions for diseases associated with amyloidosis |
| 06/11/2003 | EP1317474A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 06/11/2003 | EP1317470A1 Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy |
| 06/11/2003 | EP1317466A2 Synthons for oligonucleotide synthesis |
| 06/11/2003 | EP1317464A2 Fluorescent nucleobase conjugates having anionic linkers |
| 06/11/2003 | EP1317439A1 Acid-sensitive compounds, preparation and uses thereof |
| 06/11/2003 | EP1317289A2 High efficiency cardiac gene transfer |
| 06/11/2003 | EP1317284A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 06/11/2003 | EP1317282A2 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS |
| 06/11/2003 | EP1317278A2 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 06/11/2003 | EP1317273A1 Use of il-6r/il-6 chimera in huntington's disease |
| 06/11/2003 | EP1317182A1 Pest control system |
| 06/11/2003 | EP1158966B1 Loaded bacterial ghosts as carrier and targeting vehicles |
| 06/11/2003 | EP1119576B1 Isolation method for nucleic acid and apparatus |
| 06/11/2003 | EP1062349B1 Diisopropyl fluorophosphatase and the utilization and production thereof |
| 06/11/2003 | EP1057000A4 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY |
| 06/11/2003 | EP1051244A4 Method and articles for transfection of genetic material |
| 06/11/2003 | EP0862742B1 Assay for blood clotting factors viii and ix |
| 06/11/2003 | EP0848755B1 Vegf-related protein |
| 06/11/2003 | EP0759997B1 Use of tetracycline promoter for the strictly regulated production of recombinant proteins in prokaryotic cells |
| 06/11/2003 | EP0707641B1 An enzyme with protease activity |
| 06/11/2003 | EP0694075B1 Thermostable dna topoisomerase v |
| 06/11/2003 | EP0690873B1 Growth differentiation factor-8 |
| 06/11/2003 | EP0665886B1 Cyclin complex rearrangement and uses related thereto |
| 06/11/2003 | EP0662086B1 Protein l and hybrid proteins thereof |
| 06/11/2003 | EP0644900B1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and its use |
| 06/11/2003 | EP0638119B1 Chimeric receptor genes and cells transformed therewith |
| 06/11/2003 | EP0539492B1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
| 06/11/2003 | CN1423745A In-situ detection and analysis of methane in coal bed methane formations with spectrometers |
| 06/11/2003 | CN1423703A Process for producing L-amino via fermentation method |
| 06/11/2003 | CN1423702A Chemical inducible promoter used to obtain transgenic plants with a silent marker and organisms and cells and methods of using same for screening for mutations |
| 06/11/2003 | CN1423701A Inducible site-specific recombination for the activation and removal of transgenes in transgenic plants |
| 06/11/2003 | CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex |
| 06/11/2003 | CN1423698A The Genome of the HIV-1 inter-subtype (C/B') and use thereof |